The Latest Updates from ReSPECT Clinical Trials

ICYMI CNS 2024

#ICYMI Plus Therapeutics exhibited at the #CNS2024 Annual Meeting and Dr. John Floyd presented a ReSPECT-GBM clinical trial update Key Highlights:...

read more

LM Patient Testimonial Announcement

COMING SOON 🎗️💓 In honor of #BreastCancerAwarenessMonth, we are excited to announce that we will be sharing a patient testimonial from one of our Metastatic Breast Cancer patients who was treated for Leptomeningeal Metastases through the ReSPECT-LM Clinical Trial. She...

read more

ReSPECT-GBM Update at CNS

Plus Therapeutics presented an update on the ongoing ReSPECT-GBM Phase 1/2 clinical trial, evaluating Rhenium (186Re) Obisbemeda for the treatment of recurrent glioblastoma at the 2024 Congress of Neurological Surgeons (CNS) Annual Meeting yesterday. Key...

read more

CNS 2024

Reminder to come by Plus Therapeutics at the @CNS_update 2024 Annual Meeting at Booth #2038 Plus Therapeutics is a clinical-stage pharmaceutical company developing targeted radiotherapeutics for difficult-to-treat cancers of the central nervous system with the...

read more

#WorldCancerResearchDay

Today is #WorldCancerResearchDay! Join us in celebrating the incredible advancements in cancer research and the dedicated researchers working tirelessly to find new treatments and cures. Every breakthrough brings us one step closer to a cancer-free future🔬🌟🎗️ Learn...

read more

Happy Anniversary!

Cheers to our amazing team members at Plus Therapeutics who are celebrating their work anniversaries this last quarter! Your hard work and dedication make all the difference. Here’s to many more achievements together! 🌟 https://www.instagram.com/p/DARg_EcvLxu/

read more

Texas 5Ks

Don't forget to come by the Plus Therapeutics booth at these upcoming community events next week in Texas! Our patient advocacy team can't wait to meet you. 🎗️🧠 https://give.headforthecure.org/event/head-for-the-cure-5k-san-antonio-2024/e544230...

read more

CNS Conference Curtain Raiser

Join us as Plus Therapeutics takes the stage at the @cns_update Annual Meeting, which will be held from September 28 through October 2, 2024, at the George R. Brown Convention Center in Houston, Texas. Presentation by John Floyd, M.D., Associate Professor and Chairman...

read more

Head for the Cure Support

Our clinical and patient coordination team was honored to be a part of patient and caregiver conversations at this month's @HeadfortheCure support groups. We were so inspired to hear about everyone's journeys and share how radiotherapeutic clinical trials are working...

read more

Caregiver Support Group

Join us at the @HeadfortheCure Caregiver Conversations support group! We will discuss our ReSPECT-GBM clinical trial for Glioblastoma, patient resources, and upcoming events. respect-trials.com/gbm Join Brains for the Cure the 2nd Thursday of each month on Zoom at 7...

read more

Welcome Navin!

We would like to highlight our new Vice President of Regulatory and Quality Affairs, Navin Parwani. Plus Therapeutics is happy to have you on our team! -------------------- Navin Parwani Vice President, Quality and Regulatory Affairs Navin is the Vice President of...

read more

ABTA 2024

Another great @the_abta National Conference! 🎗️🧠 A huge thank you to their organization for hosting this event and to all the patients and caregivers who came by our booth to learn about our ongoing ReSPECT Clinical Trials. For more information, please visit:...

read more

Plus is at ABTA!

Come by our booth today and tomorrow at @the_abta national conference in Chicago! Our clinical and patient advocacy team will be on-site to share educational material and answer your questions about our ReSPECT Clinical Trials. 🌟

read more

Patient Support Group HFTC

Join us at the @HeadfortheCure Patient Perspectives support group! We will discuss our ReSPECT-GBM clinical trial for Glioblastoma, patient resources, and upcoming events. Email courtney@headforthecure.org if you would like to attend.

read more

Childhood Cancer Awareness Month 2024

September is #ChildhoodCancerAwarenessMonth and we want to raise awareness for pediatric #braincancer resources 💛 These advocacy groups have a wealth of knowledge so please follow & share to #patients & #caregivers: (More can be found on our website:...

read more

Head for the Cure Texas

Come join us at the upcoming @HeadfortheCure 5K runs in San Antonio and Houston! It’s not too late to register as we join together in the fight against brain cancer. Plus Therapeutics will run (or walk) the races and have a booth on-site to provide education about our...

read more

ABTA National Conference

We’re excited to exhibit at the ABTA National Conference! Visit our booth to learn more about our latest advancements in #braintumor treatment and support. Join us: http://abta.org/national-conference #BTSM #BrainTumorAwareness

read more

Support Group Sessions

Mark your calendars! Our clinical and patient advocacy teams will be speaking at some upcoming @HeadfortheCure patient and caregiver events. Tune in to learn about Glioblastoma and our ongoing ReSPECT-GBM clinical trial. For more information and to sign up, click...

read more

Symposium Replay

Now Streaming: Replay the live symposium by Plus Therapeutics presented at the 2024 SNO/ASCO CNS Metastases Conference in Denver, CO. Watch on YouTube: https://youtu.be/kOWF7ym0WSE

read more

ReSPECT-LM Data from SNO/ASCO

Highlights include: > Respect-LM dosing shows continued feasibility and safety of up to 44 mCi of intrathecal Rhenium (186Re) Obisbemeda > High absorbed radiation doses, mean circulating tumor cell reductions, and median overall survival of 12 months continue to...

read more